Corridor Pharmaceuticals

Launch date

2007

Employees

Market cap

Enterprise valuation

Towson Maryland (HQ)

Date	Investors	Amount	Round
Oct 2008	Quaker Bio Ventures MedImmune Ventures Red Abbey Venture Partners Acidophil	$2.3m	Angel
Oct 2009	MedImmune Ventures Red Abbey Venture Partners Osage University Partners Quaker Partners	$10.8m	Series A
Jun 2010	Quaker Bio Ventures MedImmune Ventures Red Abbey Venture Partners Maryland Health Care Product Development Osage University Partners NewSpring Capital	$13.0m	Series A
Jan 2013	N/A	$1.6m	Debt
Total Funding		$26.1m

ACQUISITION by Corridor Pharmaceuticals Jun 2010

Recent News about Corridor Pharmaceuticals